Navigation Links
James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists
Date:5/21/2013

Hackensack, NJ (PRWEB) May 21, 2013

Dr. James C. Wittig, Chief of Orthopedic Oncology (Pediatric and Adult) and Director of the Sarcoma Division of the John Theurer Cancer Center at Hackensack University Medical Center in New Jersey has been named one of the top 13 Orthopedic Oncologists in the United States by Orthopedics This Week. Dr. Wittig is one of approximately 125 surgeons in America who specialize in Orthopedic Oncology. The list was created by surveying thought leaders in the field of Oncology. Dr. Wittig’s continuous recognition validates his compassion and ongoing commitment to treating musculoskeletal cancers with the most innovative advances.

“Dr. Wittig is a sought-after specialist who is known for achieving much in the area of limb-sparing surgery. He is a real talent, and is extremely dedicated to his patients,” said one of Dr. Wittig’s peers.

The difficulties of Orthopedic oncology treatments are lessened by the advances that Dr. Wittig has achieved in his 12+ years handling an array of cases from the straightforward to the most complex ones in nature. "Although most would agree that oncology cases are the toughest, I am truly challenged by each and every diagnosis, confronting them with a customized plan as individual as each patient," notes Dr. Wittig, "leading a team that shares my commitment and personal devotion to provide an environment that fosters a continuum of extraordinary, multidisciplinary care makes the rewards of our work outstanding.”

In addition, the recent book co-authored by Dr. Wittig entitled, Operative Techniques in Orthopedic Surgical Oncology, has become invaluable in the field and is the ‘one and only’ in-depth guide to Orthopedic Oncology available today.
###

James C. Wittig, MD specializes in limb-sparing surgery; pediatric and adult bone and soft tissue sarcomas; melanoma; benign musculoskeletal tumors; metastatic cancers; as well as complex hip and knee replacement surgery. He also has special expertise with regard to tumors that affect the shoulder girdle and scapula. In addition to his Hackensack University Medical Center office located at Continental Plaza, 433 Hackensack Avenue, 2nd Floor, Hackensack, NJ, Dr. Wittig has an office at Mount Sinai Medical Center located at 5 East 98th Street, New York, NY, and a satellite office with Morristown Memorial Hospital at NJ Advanced Musculoskeletal Center, PA, 131 Madison Avenue, Suite 130, Morristown, NJ. Currently, Dr. Wittig is Chief, Orthopedic Oncology and Director, Sarcoma Division of the John Theurer Cancer Center at Hackensack University Medical Center as well as an Associate Professor of Orthopedic Surgery, Chief of Pediatric and Adult Orthopedic Oncology and the Sarcoma Program at Mount Sinai Medical Center in New York City. He is a member of the American Academy of Orthopedic Surgeons; New York State Society of Orthopedic Surgeons, Inc.; and the Medical Society of New Jersey. He has published over 90 educational materials ranging from original reports, abstracts, videos and articles in the following publications: Clinical Orthopedics and Related Research, The Journal of the American College of Surgeons, American Family Physician, Journal of Arthroplasty, Radiology and Journal of Bone and Joint Surgery. He is also a prominent lecturer in the field of Orthopedic Surgery throughout the nation. Dr. James C. Wittig has been interviewed in national and local print, TV and radio outlets including The Dr. Oz Show, New York Daily News and other publications. He has also been recognized as one of “The Nation’s Top Doctors” by New York Magazine. For more information about this or other related topics, or to schedule an appointment, please call 1-855-DRWITTIG (1-855-379-4884), visit http://www.TumorSurgery.org or email Dr. Wittig at drjameswittig(at)gmail(dot)com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10751211.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kessler Foundations James Sumowski, Ph.D., speaks at April 18-19 MS Symposium in Toronto
2. BIDMC investigator James Mier, M.D., awarded prominent grant for kidney cancer research
3. Brain researcher James Poulet receives the 2013 Paul Ehrlich Prize for Young Researchers
4. Complete Currency Trader: Review Of James Edward's Advanced Forex Trading Course Released
5. A-lign Senior Consultant James McAllister Receives QSA Certification
6. Eldon James Highlights Eco-Friendly Tubing and Fitting Assemblies at MedTec Europe
7. Dr. James Wanless on Tarot, Kathi Kennedi on Hypno-Reiki, Nina Rehzats & Teresa Figueroa on Quantum Healing, Suzy Prudden on Making Money on Dr. Carol Francis Radio Show
8. Driving While Drowsy in Buffalo: Lawyer James E. Morris Urges Motorists To Wake Up to the Facts
9. Nobel laureate James Watson publishes novel hypothesis on curing late-stage cancers
10. NAI Fellows Robert Langer, Leroy Hood and Member James Wynne receive US National Medals
11. Before Skyfall: 46 years of violence in James Bond movies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: